Treating Patients with Next Generation Therapies - Boston

Date and Time
Tuesday, May 20, 2014
3:30 PM – 7:00 PM


The Boston Sheraton Hotel
39 Dalton St.
Boston, MA 02199
Click Here for a map

Program Chair
Michele Walsh, DNP
Dana-Farber Cancer Institute (pictured)






About the Program

The Lymphoma Research Foundation's (LRF) Caring for the Lymphoma Patient: Treating Patients with Next Generation Therapies continuing education program provides an opportunity for nurses to learn about recent updates on the treatment of lymphoma and the management of the disease. The goals of the program are to increase the knowledge, skills and performance of healthcare providers and to maximize the quality of care for lymphoma patients.

Additional Information
This program is free for healthcare professionals and participants will earn 3 hours of CEU credits; however, pre-registration is required. Food and refreshments will be provided for all registered participants. Parking vouchers will be provided at the registration table for those parked in the hotel lot.

Learn from leading lymphoma experts to increase knowledge of:

  • Lymphoma and its subtypes
  • Latest therapies used to treat lymphoma
  • Managing patients with emerging B-cell therapies
  • Managing patients with emerging T-cell therapies
Program Agenda 

 Time Session/Topic

3:30 PM Registration

4:00 PM Welcome
Max Mulcahy, MPA, Lymphoma Research Foundation
Michele Walsh, DNP, Dana-Farber Cancer Institute

4:15 PM Overview of Lymphoma
Michele Walsh, DNP, Dana-Farber Cancer Institute

4:45 PMCase Studies: Managing Patients with Emerging B-cell Therapies and Bone Marrow Transplantion
Katherine Stephans, NP, Dana-Farber Cancer Institute

5:30 PMDinner Buffet

5:45 PMCase Studies: Managing Patients with Emerging T-cell Therapies
Marianne Tawa, RN, NP, Dana-Farber Cancer Institute

6:30 PMQuestions and Discussion

7:00 PMCaring for the Lymphoma Patient Concludes


This program is presented in collaboration with:



Rush University is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. Rush University designates this live activity for 3 Continuing Education credits.

This activity is being presented without bias and with commercial support. Unrestricted Education Grants from Millennium: The Takeda Oncology Company.